| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2124645 | European Journal of Cancer | 2007 | 11 Pages |
Abstract
p-HER-2 and the magnitude of Her-2 amplification were predictive of response to T and their role deserves to be analysed in larger and more homogenous T-treated populations such as those from large phase III trials.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Rosa Giuliani, Virginie Durbecq, Angelo Di Leo, Marianne Paesmans, Denis Larsimont, Jean-Yves Leroy, Marleen Borms, Anita Vindevoghel, Guy Jerusalem, Veronique D'Hondt, Luc Dirix, Jean-Luc Canon, Vincent Richard, Veronique Cocquyt, Françoise Majois,